Antimicrobial resistance among uropathogens responsible for community-acquired urinary tract infections in an Italian community

Journal of Chemotherapy
G MiragliottaA Mosca

Abstract

This study aimed to establish the pattern of the antimicrobial resistance among the leading uropathogens causing community-acquired UTIs in an area of the region of Apulia, Southern Italy. Twenty-one thousand and two hundred outpatients, 6,893 males and 14,307 females, were enrolled. Urinary isolates were identified by conventional methods and the susceptibility to 18 antimicrobials determined. Recognized uropathogens Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis were isolated from 3175 positive samples, E. coli accounting for 68.04% of positive cultures. Most overall resistance was to ampicillin, while the resistance rate to cephalothin was higher than that of third generation cephalosporins. Although to a different degree, all the bacteria had an overall good susceptibility rate to quinolones as well as to fosfomycin but increased resistance to sulfamethoxazole/trimethoprim. Our results confirm that E. coli is the leading uropathogen and provide information about the antimicrobial susceptibility patterns of the main pathogens causing community-acquired UTIs. These findings should be taken into account to help maintain the safety and efficacy of treatment for community-acquired UTIs.

References

Jan 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M Kunin
Oct 6, 1997·Infectious Disease Clinics of North America·T M Hooton, W E Stamm
Mar 3, 1999·JAMA : the Journal of the American Medical Association·K GuptaW E Stamm
Apr 4, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F W Goldstein
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C GalesR Ramphal
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K GuptaW E Stamm
Jul 10, 2003·Infectious Disease Clinics of North America·Kalpana Gupta
Jan 18, 2006·BMJ : British Medical Journal·Josip Car
Jun 28, 2007·Journal of Chemotherapy·M I Garcia GarciaUNKNOWN Spanish Cooperative Group for the Study of Anitimicrobial susceptibiltiy of Community Uropathogens

❮ Previous
Next ❯

Citations

Aug 19, 2009·Antimicrobial Agents and Chemotherapy·Sofia MarakiMatthew E Falagas
May 26, 2012·TheScientificWorldJournal·Enrico MaglianoClementina Elvezia Cocuzza
Jan 13, 2012·Urologia Internationalis·Fukashi YamamichiMasato Fujisawa
Jan 13, 2021·Infection and Immunity·Jordan R GastonChelsie E Armbruster
Mar 22, 2016·Microbiology Spectrum·Steven Clegg, Caitlin N Murphy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.